h.nwosu
TL2 · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 13 January 2025 · last posted 14d
67 posts, newest first. Showing up to 150.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #106 · Evidence › Journal club · 14 Jul 2026 · 0 likes Worth separating SURMOUNT-OSA as a question about the compound from SURMOUNT-OSA as a question about the documentation. They get answered by different people and only…
-
Insurance and replacement policies, compared Replied, post #86 · Sourcing › Logistics · 13 Jul 2026 · 0 likes I would rather this thread reach "we do not know" about insurance and replacement policies than reach a confident answer that nobody can support when asked.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #69 · Analytics › Home & field testing · 10 Jul 2026 · 8 likes Post #67 and I disagree about the size of the effect, not about the direction. My experience of Reflectance and photometric devices contradicts the reply above. I am…
-
Follow-up: Signs of dehydration worth acting on Replied, post #17 · Safety › Adverse events · 7 Jul 2026 · 31 likes Everything in post #13 holds. The case it does not cover is the one I have. Injection-site reactions that spread over a day or come with systemic symptoms are a…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #19 · Nutrition & Training › Protein & intake · 30 Jun 2026 · 0 likes Adequate protein during a substantial deficit is the part of this conversation that gets least attention and probably deserves most.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #7 · Nutrition & Training › Protein & intake · 25 Jun 2026 · 13 likes No disagreement from me. Posting only so the question does not look ignored.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #9 · Analytics › Impurities & related substances · 20 Jun 2026 · 4 likes Helpful, and short, which on this subject is harder than long.
-
Documenting a supplier's response to a discrepancy Replied, post #7 · Sourcing › Vendor reports · 2 Jun 2026 · 2 likes Reports naming a supplier need the evidence attached, which is a guideline rather than a formality. It is what makes the record usable and it is what keeps it fair.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #10 · Evidence › Journal club · 31 May 2026 · 2 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Coming back to: A structured critique template this community uses Replied, post #20 · Evidence › Study critique · 27 May 2026 · 2 likes I would rather this thread reach "we do not know" about structured critique template than reach a confident answer that nobody can support when asked.
-
Revisiting: Patterns that reliably precede a problem, documented Started this topic · Sourcing › Red flags · 18 May 2026 · 32 likes Posting this under the heading it deserves: Revisiting: Patterns that reliably precede a problem, documented Everything below is what sits behind that. Patterns, from…
-
What a good consultation looks like from the other side Replied, post #38 · Clinical › Prescriber conversations · 6 May 2026 · 14 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #16 · Compounds › Retatrutide · 19 Apr 2026 · 32 likes TRIUMPH is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #2 · Analytics › Method validation · 19 Apr 2026 · 2 likes Coming back to the opening post, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #7 · Analytics › Method validation · 15 Apr 2026 · 5 likes Everything in post #5 holds. The case it does not cover is the one I have. Accuracy: the method measures what you intend to measure. For purity methods, this is tested…
-
Spike-and-recover accuracy for a peptide assay Replied, post #18 · Analytics › Method validation · 7 Apr 2026 · 0 likes Spike-and-recover accuracy would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Reused chromatograms across lots: how to spot it Replied, post #27 · Analytics › COA interpretation · 17 Mar 2026 · 23 likes The arithmetic in post #24 is right; the assumption feeding it is the part to check. The number people quote for reused chromatograms across lots is a central estimate…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #74 · Clinical › Special populations · 15 Mar 2026 · 0 likes Taking post #71 at face value and following it one step further. Pregnancy and pregnancy planning would be much easier to settle if anyone reported the denominator.…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #142 · Analytics › COA interpretation · 28 Feb 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #111 · Practice › Interactions · 14 Feb 2026 · 0 likes The honest answer on Warfarin and altered intake is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #36 · Pharmacology › Pharmacokinetics · 8 Feb 2026 · 10 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #42 · Evidence › Trials · 2 Feb 2026 · 29 likes Post #38 describes the usual case. This is about the unusual one. Non-inferiority margins are chosen, and the choice is an argument rather than a fact. A wide margin…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #14 · Evidence › Trials · 24 Jan 2026 · 19 likes A methods point on Non-inferiority margins rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #4 · marked as the solution · Clinical › Special populations · 20 Jan 2026 · 18 likes The opening post is right about the mechanism and I think understates the practical bit. Pregnancy and breastfeeding are the clearest cases where the answer is that the…
-
The headache that turns out to be dehydration Replied, post #77 · Nutrition & Training › Hydration & electrolytes · 1 Dec 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #48 · Compounds › Oral incretins · 17 Nov 2025 · 27 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Documentation that materially improves an appeal's chances Replied, post #62 · Access › Insurance & coverage · 13 Nov 2025 · 14 likes A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is a conversation with somebody who can decide.…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #73 · Start Here › How to Ask · 8 Nov 2025 · 0 likes That is a cleaner way of putting what I was circling around.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #27 · Analytics › Method validation · 25 Oct 2025 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
-
Absolute versus relative contraindications Started this topic · Safety › Contraindications · 21 Oct 2025 · 9 likes On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. Proposing that absolute versus relative…
-
Thyroid function tests during substantial weight change Replied, post #97 · Clinical › Bloodwork · 15 Oct 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed thyroid function tests during substantial, as opposed to read about it? The thread is…
-
Managing an unplanned gap in supply — what changed since Replied, post #87 · Access › Shortages · 14 Oct 2025 · 10 likes Post #86 is right about the mechanism and I think understates the practical bit. Device availability and compound availability are separate supply chains and the device…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #7 · Practice › Side effects · 11 Oct 2025 · 4 likes Adding a null result on Dizziness on standing. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Sleep quality changes during weight loss — what changed since Replied, post #7 · Wellbeing › Sleep · 23 Sep 2025 · 5 likes Post #5 describes the usual case. This is about the unusual one. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea…
-
What I would record differently if I started again — the long version Replied, post #10 · Outcomes › Progress reports · 16 Sep 2025 · 20 likes This is the sort of exchange that makes the archive worth searching.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #18 · Evidence › Study critique · 12 Sep 2025 · 14 likes Where I part company with post #16, and it is a narrow parting. Statistical significance and clinical importance are different and both are needed. A significant…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #103 · Data & Tools › Datasets · 10 Sep 2025 · 7 likes Since Aggregated purity results across four keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #64 · Analytics › HPLC & UHPLC · 9 Sep 2025 · 29 likes Worth separating two things that post #60 runs together. On Resolution and tailing factor: the maintained page in the documentation commons covers the general case with…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #76 · Evidence › Journal club · 4 Sep 2025 · 0 likes Worth separating orforglipron phase 2 as a question about the compound from orforglipron phase 2 as a question about the documentation. They get answered by different…
-
A ten-fold dose error caught before injection Replied, post #71 · Devices › Syringes & needles · 26 Jul 2025 · 18 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #19 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 0 likes Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #7 · Evidence › Meta-analyses · 19 Jun 2025 · 33 likes Everything in post #3 holds. The case it does not cover is the one I have. Practical note on random versus fixed effects: write down what you expect before you look.…
-
Coming back to: What happens when a maintainer goes quiet Replied, post #3 · Documentation › Doc review · 19 Jun 2025 · 27 likes This follows post #2 rather than contradicting it. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #104 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 3 likes Posting my Tracking intake numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #42 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 1 like Post #39 is the version of this I will quote in future. One addition. Distribution across the day appears to matter less than total for most outcomes, and it matters…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #59 · Outcomes › Body composition · 18 May 2025 · 1 like Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology. Written from…
-
Fibre intake when total intake falls, and the constipation link Replied, post #58 · Nutrition & Training › Protein & intake · 24 Apr 2025 · 0 likes Post #54 put the caveat in the right place and I want to underline it. Tracking intake for a week rather than permanently is usually enough to find out whether there is…
-
About the Progress reports category Replied, post #5 · Outcomes › Progress reports · 7 Apr 2025 · 17 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on. That…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #27 · Sourcing › Vendor reports · 15 Mar 2025 · 20 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
Consistent declarations and why they matter more than clever ones Replied, post #159 · Sourcing › Logistics · 10 Mar 2025 · 6 likes Post #155 put the caveat in the right place and I want to underline it. Consistent declarations has been discussed here with more heat than it deserves, mostly because…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #22 · Compounds › Other compounds · 15 Feb 2025 · 3 likes Building on post #21 rather than restating it. Careful with the language on research a compound. "Not detected" and "not present" are different findings and the first…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #62 · Compounds › Semaglutide · 13 Feb 2025 · 3 likes Post #58 describes the usual case. This is about the unusual one. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #7 · Access › International · 21 Jan 2025 · 15 likes Picking up post #4: that is the part I would want checked first. The honest answer on Cross-border purchase within is that it depends, and the useful part is the list…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #26 · Evidence › Journal club · 19 Jan 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
What changed in 2026, by region Replied, post #84 · Access › International · 18 Jan 2025 · 19 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end. It is worth checking rather than…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #10 · Practice › Reconstitution · 9 Jan 2025 · 20 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
Coming back to: When to suspect the method rather than the sample Replied, post #88 · Analytics › Method validation · 17 Dec 2024 · 20 likes A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many…
-
Coming back to: When to suspect the method rather than the sample Replied, post #63 · Analytics › Method validation · 12 Dec 2024 · 11 likes Coming back to post #61, because the follow-up matters more than the original answer. Stability-indicating method: one that can separate a compound from its degradation…
-
A promotion I argued against, and why I lost Replied, post #18 · Documentation › Doc review · 1 Dec 2024 · 7 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
-
Fixed versus detachable needles: the trade-offs Started this topic · Devices › Syringes & needles · 10 Nov 2024 · 50 likes Posting this under the heading it deserves: Fixed versus detachable needles: the trade-offs Everything below is what sits behind that. I was wrong about fixed versus…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #34 · Wellbeing › Mental health · 16 Oct 2024 · 1 like If you are new and reading this thread for the answer to Food noise: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
-
Blind submission and why it changes minds Replied, post #70 · Sourcing › Independent verification · 25 Sep 2024 · 31 likes Post #67 is the version of this I will quote in future. One addition. Nobody has said the unglamorous part of blind submission yet, so: most of the variation is…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #23 · Practice › Administration · 12 Sep 2024 · 1 like Everything in post #21 holds. The case it does not cover is the one I have. Site rotation scheme would be much easier to settle if anyone reported the denominator.…
-
Request: a diff view for wiki revisions Replied, post #8 · Meta › Feature requests · 30 Aug 2024 · 17 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. That is the version I would defend. It is not the version I…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #13 · Sourcing › Independent verification · 23 Aug 2024 · 20 likes Post #10 put the caveat in the right place and I want to underline it. Nobody has said the unglamorous part of Splitting a vial yet, so: most of the variation is…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #14 · Compounds › Semaglutide · 20 Aug 2024 · 3 likes On post #10 — agreed on the reasoning, with one qualification. Two people in this thread mean different things by c-cell question and are disagreeing about the…
-
What happens when a maintainer goes quiet Replied, post #5 · Documentation › Doc review · 19 Jun 2024 · 0 likes Approving a document you have not read is worse than not responding, and it happens because approval feels supportive.